Gary Anthony Pestano - 10 Nov 2025 Form 4 Insider Report for BIODESIX INC (BDSX)

Signature
/s/ Robin H. Cowie as Attorney-in-Fact for Gary Pestano
Issuer symbol
BDSX
Transactions as of
10 Nov 2025
Net transactions value
-$175
Form type
4
Filing time
13 Nov 2025, 16:54:07 UTC
Previous filing
14 Aug 2025
Next filing
06 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pestano Gary Anthony Chief Development Officer 919 WEST DILLON RD, LOUISVILLE /s/ Robin H. Cowie as Attorney-in-Fact for Gary Pestano 13 Nov 2025 0001827711

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDSX Common Stock Options Exercise +69 +0.87% 7,962 10 Nov 2025 Direct F1, F2
transaction BDSX Common Stock Sale $175 -23 -0.29% $7.62 7,939 10 Nov 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSX Restricted Stock Units Options Exercise $0 -69 -50% $0.000000 68 10 Nov 2025 Common Stock 69 Direct F1, F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025.
F2 Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F3 These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs.
F4 These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.